Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BP1.4979 in Primary Premature Ejaculation
NCT07047404Phase 2Recruiting
- Sponsor
- Bioprojet
- Start
- Sep 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BP-1.4979 in premature ejaculation (PE), sponsored by Bioprojet. Started Sep 2025; status: recruiting.
02
Drugs
BP-1.4979
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT07047404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07047404.